UCN2 and myopathy: However, weakness dominating in legs more than arms has been described.1 Suzuki et al. found a chronic form of myopathy in 5% with anti-SRP antibodies, in line with a previous report by Dimitri et al.2–3 Patients with anti-SRP and a chronic presentation tend to be younger, and with poorer response to therapy.2